Great Point Partners LLC Sangamo Therapeutics, Inc Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $14.7 Million - $28.9 Million	-1,589,724 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $92,233 - $122,715	9,833 Added 0.62%	1,589,724 $15 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $5.88 Million - $11.2 Million	946,386 Added 149.39%	1,579,891 $14.2 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $3.2 Million - $5.61 Million	633,505 New	633,505 $4.04 Million

110

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $186M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.